For decades, the standard treatment for these potentially ... benralizumab could become the first new therapy approved for eosinophilic exacerbations of asthma and COPD in over 50 years.

Here are four drug and biotech stocks, ARQT, MESO, MNPR and KOD, which have more than doubled in 2024 with room for further ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. The Conversation Last Updated : 01 December 2024, 08:55 IST ...

New Study Shows Promising Results for COPD Treatment Nov. 20, 2024 — A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave ...

The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD flare-ups seen in 50 years, following promising clinical trial data.

we can inspire innovative and expedited therapeutic solutions for COPD," Dr. Hamilton said. "This will give us the opportunity to maximize the treatment benefit of new therapies for patients." ...

New biologic drugs for chronic obstructive ... The therapeutic goals of biologics remain the same as with other treatments for COPD, namely restoration of normal inflammatory response and ...

A novel way of scanning lungs can demonstrate the impact of treatment on lung function in real-time, allowing experts to ...

A new method of scanning lungs is able to show in real time how air moves in and out of the lungs as people take a breath in patients with asthma, chronic obstructive pulmonary disease (COPD), and ...

Dupixent becomes the first-ever targeted therapy for patients with COPD, the first biologic for the disease, and the first new treatment approach in Europe in over a decade. It has been cleared ...

Scientists at Newcastle University in the UK have developed a groundbreaking scanning technique that shows how lungs work ...